Saturday 6th November 2021
10am - 6pm GMT
Save the date!
Anyone and Everyone is encouraged to come! Previous delegates have included students, academics, policy makers and members of the public.
Dr. Roopa Dhatt is a passionate advocate for gender equality in global health and a leading voice in the movement to correct the gender imbalance in global health leadership. Determined to build a movement to transform women’s leadership opportunities in health, Dr. Dhatt co-founded Women in Global Health in 2015. Today, Women in Global Health has more than 25 chapters and 50,000 supporters in more than 90 countries and continues to grow. Dr. Dhatt, the Executive Director, and the global team work with a network of WGH chapters in every region to challenge power and privilege for gender equity in health by mobilizing a diverse group of emerging women health leaders, by advocating existing global health leaders commit to transforming their own institutions, and by holding these leaders to account. With more than 25 chapters in all regions, Women in Global Health is changing the conversation about women’s leadership in health at global, national
and local levels.
In recognition of her work advancing gender equality in health, Dr. Dhatt was recognized in the Gender Equality Top 100, the most influential people in global policy 2019. She was recently recognized in the Lancet. She was invited as a public delegate the historic United States Government Delegation to the United Nations 65th Commission of Status of Women Meeting in March 2021, which was led by Vice President Kamala Harris and Ambassador Thomas-Greenfield. She is also a member of the Lancet COVID-19 Commission, Global Health Diplomacy and Cooperation Task Force.
Dr Roopa Dhatt
Ezgi Türkçelik graduated from Department of Psychology, Middle East Technical University (METU) in 2006 and completed her master's degree at Lund University Gender Studies Program with a Swedish Institute Scholarship in 2010. She has been continuing her PhD study on bystander intervention in the context of violence against women at Social Psychology programme at METU.
Since 2011, She has been working as a gender specialist at Başkent University Women and Child Health Research and Implementation Center (BUWCRIC), and as a lecturer in the Public Health Department of the same university since 2013. She teaches Gender and Health, Violence Against Women, Factors Affecting Women's Health and Gender. She has worked as a trainer and gender expert in number of international and national projects on gender equality and violence against women, prevention of child marriages and monitoring health with gender indicators.
She is the mother of Çınar and Toprak Alaz.
Laure is an Associate in the Global Vaccines Delivery team at the Clinton Health Access Initiative (CHAI). She supports country teams and governments in strengthening infant and Covid immunization programmes. Prior to joining CHAI, Laure worked as a Freelance Consultant for a range of global health policy clients, building on her three years' experience at MHP Communications, a policy and advocacy consultancy, specialising in the health sector. Laure launched her career in global health with an internship at the Centre on Global Health Security at Chatham House and ongoing volunteering for the Global Health 50/50 initiative.
Dr Isaac Ghinai
Dr Ghinai is a public health physician and epidemiologist. His research is focused on the application of molecular epidemiology to the control of newly emerging pathogens and the elimination of endemic infectious diseases, particularly those disproportionately affecting economically-marginalized communities.
He currently serves as the Medical Director for Laboratory-Based Surveillance at the Chicago Department of Public Health, where he leads genomic and wastewater surveillance efforts for three million Chicago residents. Prior to this, as a CDC Epidemic Intelligence Service Officer, he led the public health response to the first known human-to-human transmission of SARS-CoV-2 in the USA, and led a large multistate team investigating a novel lung injury associated with e-cigarette use.
Before moving to the US, he was an Academic Clinical Fellow at the University of Oxford, utilizing genomic epidemiology for the control of multidrug-resistant P.falciparum malaria in Southeast Asia and sub-Saharan Africa. He has worked in clinical practice, public health or infectious disease research in Southeast Asia (Cambodia and Myanmar), sub-Saharan Africa (Kenya, Namibia, Zambia), Europe (UK and refugee camps in Greece) and North America (USA).
Dr Shakira Choonara
Dr Shakira Choonara is multi award-winning public health practitioner, bold activist, and Operation Smile Ambassador for South Africa (SA). She currently serves as a Technical Support Specialist at the World Health Organization, supporting the development of the SRH-UHC Learning by Sharing Portal and the Working for Health Programme. She is a start-up entrepreneur and founder of a development consultancy firm. At present, Dr Choonara is the incumbent Lancet Commissioner for Adolescent Health and Wellbeing. Dr Choonara previously served on the inaugural African Union Youth Council 2018-2020.
Dr Choonara is a recipient of a number of prestigious awards including being listed as the Mail and Guardian 50 Most Powerful Women, Destiny Magazine’s Most Powerful Woman under 40, 100 influential Young Africans and the Woman of the Year in Health in SA. Dr Choonara attained her PhD (Public Health) at the age of 27 years, an Honours (Cum Laude) and Masters in Demography from the University of the Witwatersrand, South Africa.
She is widely recognised for her work and experience as a researcher and advocacy specialist, focusing on health policy and systems research, specifically universal health coverage, gender equality, sexual and reproductive health rights, non-communicable diseases, HIV and youth development. She is currently a Board Member of Youth Health Africa focusing which focuses on youth, HIV and addressing unemployment in South Africa.
Dr Catrin Moore
Dr. Catrin Moore’s research focuses on Antimicrobial resistance, often termed the silent pandemic, which is on the increase in many LMICs. Dr. Moore has been in the University of Oxford for over twenty years in the Global arena, and her DPhil was based in Oxford and Thailand. She moved to South East Asia following her DPhil to build the local capacity in-country and ran diagnostic and research clinical microbiology laboratories for six years (based in Laos and Cambodia). Dr. Moore returned to the UK in 2012 to join the Modernising Medical Microbiology laboratory, where she led a stream of work performing whole genome sequencing on Streptococcus pneumoniae. She moved to the Epidemic diseases Research Group Oxford in 2015, where she managed an Ebola clinical trial and led several genomic studies on avian influenza.
Dr. Moore joined the Big Data Institute in May 2018, where she leads the Oxford Global Burden of Disease (GBD) group on the Global Research on AntiMicrobial resistance (GRAM) project. Partnered with the Institute for Health Metrics and Evaluation (IHME) in Seattle and Tropical Medicine in Oxford, they analyse global data to produce health metrics and geospatial maps on antimicrobial resistance (AMR). Utilizing methodologies applied in IHME’s ongoing Global Burden of Disease (GBD) study, the partnership builds global evidence on AMR with an initial focus on a select number of disease-resistant infections. Dr. Moore also works on studies to improve the use of diagnostic tools, training, and communication in low- and middle-income countries (LMICs) to treat patients presenting to outpatient facilities to reduce the unnecessary prescribing of antibiotics.
Prof. Raquel Duarte-Davidson
Professor Raquel Duarte-Davidson heads the Chemicals and Environmental Effects Department of the UK Health Security Agency (UKHSA). Her Department provides high level scientific advice on environment and public health and extreme events and health, environmental epidemiology and chemical risk assessment. She co-Directs the Health Protection Research Unit (HPRU) on Climate and Environmental Change and Health (ECH) with London School of Hygiene and Tropical Medicine (LSHTM) and commissions the UK National Poisons Information Service (NPIS). Raquel manages large research contracts involving multi-partners in Europe and internationally on topics ranging from public health risks associated with environmental exposures to chemicals and poisons, planning, preparedness, response and recovery from chemical incidents (acute and chronic exposures) and alerting and notification of cross boundary chemical incidents. Raquel has co-authored over 140 papers in peer review journals and books.
Raquel is also an independent expert on the European Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) and the Chair on SCHEER’s rapid risk assessment working group and Honorary Professorships at Exeter and Cranfield Universities. Prior to joining UKHSA (Public Health England until September 2021) she was a Principal Scientist at the Environment Agency, responsible for implementing the Agency’s chemical risk assessment policy.